← Eichor
Condition: Hereditary Leiomyomatosis And Renal Cell Cancer Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hereditary Leiomyomatosis And Renal Cell Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT00001238Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT00050752An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy
NA · 1 location(s) · University of Texas Southwestern Medical Center · NCT04623502MyVHL: Patient Natural History Study
Phase N/A · 1 location(s) · Joshua Mann, MPH · NCT03749980Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer
Phase 2 · 13 location(s) · National Cancer Institute (NCI) · NCT04981509
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.